LINC01176: A Potential Drug Target and Biomarker (G100506516)

Target Name: LINC01176

NCBI ID: G100506516

LINC01176

Other Name(s): Long intergenic non-protein coding RNA 1176 | long intergenic non-protein coding RNA 1176

LINC01176: A Potential Drug Target and Biomarker

LINC01176 is a protein that is expressed in various tissues of the human body, including the brain, heart, liver, and pancreas. Its full name is long non-coding RNA-encoded RNA 225566, and it is also known as lncRNA-RISC. LINC01176 has been shown to play a role in various cellular processes, including cell signaling, DNA replication, and metabolism.

One of the most promising aspects of LINC01176 is its potential as a drug target. LINC01176 has been shown to interact with several protein molecules, including the transcription factor ASXL1, which is known to play a role in cancer progression. Additionally, LINC01176 has been shown to interact with the protein PDGF-BB, which is involved in cell signaling and has been linked to various diseases, including cancer.

Another potential use of LINC01176 as a drug target is its role in the development of certain diseases. For example, LINC01176 has been shown to be expressed in the brains of individuals with Alzheimer's disease, a condition that is characterized by the progressive loss of brain cells. Additionally, LINC01176 has been shown to be involved in the development of certain cardiovascular diseases, such as heart failure and diabetic neuropathy.

In addition to its potential as a drug target, LINC01176 has also been shown to be a potential biomarker for several diseases. For example, LINC01176 has been shown to be a potential biomarker for Alzheimer's disease, as its expression has been shown to be associated with the development of this condition. Additionally, LINC01176 has been shown to be a potential biomarker for cancer, as its expression has been shown to be associated with the development of certain types of cancer.

Overall, LINC01176 is a protein that has significant potential as a drug target and biomarker. Its interaction with the transcription factor ASXL1 and its potential involvement in the development of certain diseases make it an attractive candidate for further research and development. Further studies are needed to fully understand the role of LINC01176 in these processes and to determine its potential as a drug.

Protein Name: Long Intergenic Non-protein Coding RNA 1176

The "LINC01176 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01176 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets